MK-5684-003: A PHASE 3 STUDY OF CYP11A1 INHIBITOR OPEVESOSTAT VERSUS NEXT-GENERATION HORMONAL AGENT (NHA) SWITCH IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AFTER NHA AND TAXANE-BASED CHEMOTHERAPY
DOI:
10.1016/j.urolonc.2024.12.066
Publication Date:
2025-02-27T16:03:02Z
AUTHORS (7)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....